ASTRAZENECA PHARMA Surges by 13%; BSE HEALTHCARE Index Up 5.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 14th April, 2021 on account of Dr. Baba Saheb Ambedkar Jayanti.

ASTRAZENECA PHARMA Surges by 13%; BSE HEALTHCARE Index Up 5.2%
Fri, 20 Mar 03:02 PM

ASTRAZENECA PHARMA share price has zoomed 13% and is presently trading at Rs 2,429.

Meanwhile, the BSE HEALTHCARE Index is at 12,166 (up 5.2%).

Among the top Gainers in the BSE HEALTHCARE Index today are ASTRAZENECA PHARMA (up 13.3%) and ABBOTT INDIA (up 13.8%).

FDC LTD. (down 0.2%) and AJANTA PHARMA (down 0.3%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 1,938 to Rs 2,429, registering a gain of Rs 491 (up 21.3%).

On the other hand, the BSE HEALTHCARE has moved down from 14,270 to 12,166, loss of 2,104 points (down 15.9%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 105.4%), J.B.CHEMICALS (up 56.0%) and IPCA LABS (up 52.3%).

India's Revival: A Once-in-a-Generation Wealth Making Opportunity

What About the Benchmark Indices?

The BSE Sensex is at 30,418 (up 5.1%).

The top gainers among the BSE Sensex stocks today are ONGC (up 17.7%), HUL (up 11.2%) and RELIANCE IND. (up 10.1%). Other gainers include TCS (up 9.2%) and ULTRATECH CEMENT (up 8.7%). The most traded stocks in the BSE Sensex are ONGC and SBI.

In the meantime, NSE Nifty is at 8,883 (up 5.2%). The top gainers in the NSE Nifty include ONGC (up 17.9%), GAIL (up 14.9%) and BHARTI INFRATEL (up 14.9%). Other gainers include DR. REDDYS LAB (up 11.3%) and HUL (up 11.0%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,363 to 30,418, registering a loss of 7,945 points (down 22.48%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit down at Rs 144 million for the quarter ended September 2019, compared to a loss of Rs 291 million a year ago. Net Sales declined 3.1% to Rs 2.1 billion during the period as against Rs 2.2 billion in July-September 2018.

For the year ended March 2018, ASTRAZENECA PHARMA reported 29.2% increase in net profit to Rs 259.0 million compared to net profit of Rs 200.0 million during FY17.

Revenue of the company grew 4.3% to Rs 6 billion during FY18.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 78.5x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Surges by 13%; BSE HEALTHCARE Index Up 5.2%". Click here!

  

Stock Market Updates

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers (Today's Market)

Apr 13, 2021 Closing

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Sensex Trades Marginally Higher, Dow Futures Up by 17 Points (Today's Market)

Apr 13, 2021 12:30 pm

BSE Sensex is trading up by 167 points, while the NSE Nifty is trading up by 50 points.

Indian Share Markets Open Marginally Higher; ONGC and M&M Top Gainers (Today's Market)

Apr 13, 2021 09:30 am

Indian share markets open in green. The BSE Sensex opened up by 156 points, while the Nifty is trading higher by 52 points.

HEG Share Price Up by 5%; BSE CAPITAL GOODS Index Up 0.7% (Today's Market)

Apr 13, 2021 09:32 AM

HEG share price is trading up by 5% and its current market price is Rs 2,177. The BSE CAPITAL GOODS is up by 0.7%. The top gainers in the BSE CAPITAL GOODS Index are HEG (up 5.3%) and GRAPHITE INDIA (up 7.5%). The top losers are KALPATARU POWER (down 0.1%) and HONEYWELL AUTOMATION (down 0.4%).

BANK OF MAHARASHTRA Share Price Up by 6%; BSE BANKEX Index Up 1.0% (Today's Market)

Apr 13, 2021 09:32 AM

BANK OF MAHARASHTRA share price is trading up by 6% and its current market price is Rs 24. The BSE BANKEX is up by 1.0%. The top gainers in the BSE BANKEX Index is BANK OF MAHARASHTRA (up 5.9%). The top losers is KOTAK MAHINDRA BANK (down 0.3%).

ADANI PORTS & SEZ Share Price Down by 5%; BSE 500 Index Up 0.1% (Today's Market)

Apr 13, 2021 09:26 AM

ADANI PORTS & SEZ share price is trading down by 5% and its current market price is Rs 755. The BSE 500 is up by 0.1%. The top gainers in the BSE 500 Index are GRAPHITE INDIA (up 5.4%) and GSK CONSUMER (up 5.1%). The top losers are ADANI PORTS & SEZ (down 5.3%) and MAH. SCOOTERS (down 5.2%).

View More Indian Share Market News

Most Popular

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This...(Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

S&P BSE SENSEX


Apr 13, 2021 (Close)

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
FOLLOW
  • Follow on YouTube
  • Follow on LinkedIn Follow @Equitymaster Follow on RSS Follow on Telegram

APP
  • Get Equitymaster Android App on Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.